Advertisement

Search Results

Advertisement



Your search for ANDREW W. HAHN, MD, PAVLOS MSAOUEL, MD, PhD, AND NIZAR M. TANNIR, MD, FACP,ANDREW W. HAHN, MD, PAVLOS MSAOUEL, MD, PhD, AND NIZAR M. TANNIR, MD, FACP matches 1 pages

Showing 1 - 1


kidney cancer

CLEAR Trial: Is Lenvatinib Plus Pembrolizumab the Best First-Line Immunotherapy Doublet in Metastatic Renal Cell Carcinoma?

At the 2021 Genitourinary Cancers Symposium, Motzer et al presented the clinical results of the CLEAR trial, adding a novel regimen, lenvatinib plus pembrolizu-mab, to the growing armamentarium of first-line treatments for patients with metastatic clear cell renal cell carcinoma (RCC). The...

Advertisement

Advertisement



Advertisement